Canesten®

	Next higher product group	clotrimazol (INN)
	Status	1973-01-01 registration start
	Status	1998-01-01 sales existent
	Organisation	Bayer (Group)

Record changed: 2011-11-25

More documents for antimycotic

[1] Basilea Pharmaceutica Ltd.. (12/14/12). "Press Release: Basilea Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-threatening Fungal Infections". Basel....
[2] Basilea Pharmaceutica Ltd.. (12/10/12). "Press Release: Basilea Appoints Ronald Scott as CEO to Succeed Anthony Man and Expands Management Team". Basel....
[3] Evolva S.A.. (12/14/09). "Press Release: Evolva Raises Additional CHF 21 Million. Evolva SA Completes Merger with Arpida Ltd – Listing on SIX Swiss Exchange Under Name Evolva Holding AG". Reinach....
[4] Basilea Pharmaceutica Ltd.. (10/20/08). "Press Release: Basilea Announces new Data to Be Presented on Ceftobiprole and Isavuconazole at ICAA/IDSA". Basel....
[5] Novartis. (8/29/08). "Press Release: Novartis Decides Not to Pursure further Development of Aurograb™. Aurograb™ Decision Reached after Phase II Results Show Lack of Efficacy as an Add-on Therapy for Life-threatening Bacterial Infections". Basel....
[6] Intercell AG. (4/21/08). "Press Release: Strong Alliance to Fight Fungal Infections. Intercell and Its Partner Institutions Are Awarded an EU Grant for Targeting Research and Novel Treatment of Fungal Infections". Vienna....
[7] Basilea Pharmaceutica Ltd.. (4/18/08). "Press Release: New Scientific Data on Ceftobiprole and Isavuconazole Will Be Presented at ECCMID". Basel....
[8] Basilea Pharmaceutica Ltd.. (4/15/08). "Press Release: Basilea Opens new Phase III Study in Special Patient Populations for Its Broad-spectrum Antifungal Isavuconazole". Basel....
[9] FDA. (9/28/07). "Press Release: FDA Approves Lamisil for Pediatric Treatment of Scalp Ringworm"....
[10] Schering-Plough Corporation. (1/25/07). "Press Release: The New England Journal of Medicine Publishes Two Landmark Studies of Noxafil® (Posaconazole) in the Prevention of Invasive Fungal Infections". Kenilworth, NJ....

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top

Top News

Upcoming Events

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Partners

Canesten®

More documents for antimycotic